Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yonghe Medical Group CoHKSE:02279 +5.51%84 EV-to-FCF is 1.08 as of Aug. 21, 2026, which is 23% below its 10-year median of 1.40. GuruFocus rates HKSE:02279 with a GF Score™ of 84/100 and a GF Value™ of HK$2.01 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 408 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks better than 95.34% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Yonghe Medical Group Co's Enterprise Value is HK$659 Mil.
Yonghe Medical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$611 Mil. Therefore, Yonghe Medical Group Co's EV-to-FCF for today is 1.08.
The historical rank and industry rank for Yonghe Medical Group Co's EV-to-FCF or its related term are showing as below:
HKSE:02279'
s EV-to-FCF Range Over the Past 10 Years
Min: -14.64 Med: 1.4 Max: 23.06
Current: 1.08
During the past 8 years, the highest EV-to-FCF of Yonghe Medical Group Co was 23.06. The lowest was -14.64. And the median was 1.40.
HKSE:02279's EV-to-FCF is ranked better than 95.34% of 408
companies
in the Healthcare Providers & Services industry
Industry Median: 18.7
vs HKSE:02279: 1.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Yonghe Medical Group Co (HKSE:02279) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Yonghe Medical Group Co's PE Ratio (TTM) for today is calculated as:
Yonghe Medical Group Co's share price for today is HK$2.49.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yonghe Medical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.273.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's EV-to-FCF falls into.
Yonghe Medical Group Co's current Enterprise Value is HK$659 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yonghe Medical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$611 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yonghe Medical Group Co (HKSE:02279) has a EV-to-FCF of 1.08 as of Aug. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Yonghe Medical Group Co and its competitors. This is 23% below median its historical median of 1.40. According to the industry distribution chart, Yonghe Medical Group Co ranks #19 out of 408 companies in the Healthcare Providers & Services industry, placing it in the top 4.7%.
Is Yonghe Medical Group Co's EV-to-FCF too high?
Yonghe Medical Group Co's current EV-to-FCF of 1.08 is 23% below median its 10-year median of 1.40. The Healthcare Providers & Services industry median EV-to-FCF is 18.70. Yonghe Medical Group Co's value of 1.08 is 94.2% below this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #19 out of 408 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #19 out of 408 companies for EV-to-FCF. This places Yonghe Medical Group Co in the top 5% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 18.70. Yonghe Medical Group Co's value of 1.08 is 94.2% below this benchmark. While the company's 10-year median is 1.40 vs. the industry median of 18.70, Yonghe Medical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.70, based on 408 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current EV-to-FCF of 1.08 is 94.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current EV-to-FCF is 1.08, which is 23% below median its own 10-year median of 1.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yonghe Medical Group Co (HKSE:02279) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$2.01, compared to a current price of HK$2.49 — trading 23.9% above its estimated fair value. The current EV-to-FCF is 1.08, which is 23% below median its 10-year median of 1.40 and 94.2% below the Healthcare Providers & Services industry median of 18.70. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Yonghe Medical Group Co (HKSE:02279), the current EV-to-FCF is 1.08 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (HKSE:02279) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of HK$2.49 is trading 23.9% above its estimated GF Value™ of HK$2.01.
GuruFocus considers Yonghe Medical Group Co to be Modestly Overvalued.
Key valuation signals for HKSE:02279:
EV-to-FCF: 1.08 (23% below median its 10-year median of 1.40)
GF Value™: HK$2.01 vs. price of HK$2.49 (23.9% above fair value)
Industry Position: 94.2% below the Healthcare Providers & Services median (#19 of 408)
No single metric tells the full story. See the HKSE:02279 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for HKSE:02279
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02279 has been successfully added to your 
